Difference between revisions of "Clopidogrel (Plavix)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replace - "or the prescribing information<ref name="insert"></ref>." to "or the prescribing information.<ref name="insert"></ref>")
m (Text replacement - "please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [https://online.lexi.com/lco/action/login UpToDate Lexidrug], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information" to "please refer to your preferred pharmacopeias or the prescribing information")
 
(13 intermediate revisions by 4 users not shown)
Line 1: Line 1:
 
==General information==
 
==General information==
Class/mechanism: Irreversible thienopyridine class inhibitor of the P2Y12 class of adenosine diphosphate (ADP) receptors on platelets, inhibiting platelet activation and aggregation.<ref name="insert">[http://products.sanofi.us/PLAVIX/plavix.pdf Clopidogrel (Plavix) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/clopidogrel.pdf Clopidogrel (Plavix) package insert (locally hosted backup)]</ref><ref>[http://www.plavix.com Plavix manufacturer's website]</ref>
+
Class/mechanism: Irreversible thienopyridine class inhibitor of the P2Y<sub>12</sub> class of adenosine diphosphate (ADP) receptors on platelets, inhibiting platelet activation and aggregation.<ref name="insert">[http://products.sanofi.us/PLAVIX/plavix.pdf Clopidogrel (Plavix) package insert]</ref><ref>[[:File:Clopidogrel.pdf | Clopidogrel (Plavix) package insert (locally hosted backup)]]</ref>
 
<br>Route: PO
 
<br>Route: PO
 
<br>Extravasation: n/a
 
<br>Extravasation: n/a
  
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
+
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.<ref name="insert"></ref>
  
 
==Patient drug information==
 
==Patient drug information==
*[http://www.plavix.com/Plavix%20Med%20Guide.pdf Clopidogrel (Plavix) manufacturer's patient information]<ref>[http://www.plavix.com/Plavix%20Med%20Guide.pdf Clopidogrel (Plavix) manufacturer's patient information]</ref>
+
*[http://products.sanofi.us/PLAVIX/plavix.pdf Clopidogrel (Plavix) package insert]<ref name="insert"></ref>
*[http://products.sanofi.us/PLAVIX/plavix.pdf#page=7 Clopidogrel (Plavix) package insert PDF pages 7-8]<ref name="insert"></ref>
+
*[https://packageinserts.bms.com/medguide/medguide_plavix.pdf Clopidogrel (Plavix) medication guide]<ref>[https://packageinserts.bms.com/medguide/medguide_plavix.pdf Clopidogrel (Plavix) medication guide]</ref>
 
*[http://www.uptodate.com/contents/clopidogrel-patient-drug-information Clopidogrel (Plavix) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/clopidogrel-patient-drug-information Clopidogrel (Plavix) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/clopidogrel-patient-drug-information Clopidogrel (Plavix) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/clopidogrel-patient-drug-information Clopidogrel (Plavix) patient drug information (UpToDate)]</ref>
 +
 +
==Also known as==
 +
*'''Brand names:''' Bio-Clopi, Ceruvin, Clop-75, Clopalvix, Clopicard, Clopidro, Clopinam, Deviplat, Lopigrol, Plagril, Plavix, Stroka
  
 
==References==
 
==References==
 
<references/>
 
<references/>
 +
 +
[[Category:Drugs]]
 +
[[Category:Oral medications]]
 +
 +
[[Category:P2Y12 ADP inhibitors]]
 +
 +
[[Category:FDA approved in 1997]]

Latest revision as of 01:01, 29 June 2024

General information

Class/mechanism: Irreversible thienopyridine class inhibitor of the P2Y12 class of adenosine diphosphate (ADP) receptors on platelets, inhibiting platelet activation and aggregation.[1][2]
Route: PO
Extravasation: n/a

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.[1]

Patient drug information

Also known as

  • Brand names: Bio-Clopi, Ceruvin, Clop-75, Clopalvix, Clopicard, Clopidro, Clopinam, Deviplat, Lopigrol, Plagril, Plavix, Stroka

References